Evidence map›Paper›PMID 42383813›Full record

ArticleInvestigative ophthalmology & visual science2026

Myd88 Deficiency Accelerates Retinal Degeneration and Alters Microglial Dynamics in a Mouse Model of Retinitis Pigmentosa.

Shotaro Shimokawa, Sakurako Shimokawa, Huanyu Zhao, Jun Funatsu, Takahiro Hisai, Kaho Yamamoto, Shunji Nakatake, Kohta Fujiwara, Ayako Okita, Yoshito Koyanagi and 8 more

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Shotaro ShimokawaDepartment of Ophthalmology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
Sakurako ShimokawaDepartment of Ophthalmology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
Huanyu ZhaoDepartment of Ophthalmology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
Jun FunatsuDepartment of Ophthalmology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
Takahiro HisaiDepartment of Ophthalmology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
Kaho YamamotoDepartment of Ophthalmology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
Shunji NakatakeDepartment of Ophthalmology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
Kohta FujiwaraDepartment of Ophthalmology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
Ayako OkitaDepartment of Ophthalmology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
Yoshito KoyanagiDepartment of Ophthalmology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
Shoji NotomiDepartment of Ophthalmology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
Keijiro IshikawaDepartment of Ophthalmology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
Nobuyo YawataDepartment of Ocular Pathology and Imaging Science, Kyushu University, Fukuoka, Japan.
Noriko YoshidaDepartment of Clinical Research Center, Faculty of Medicine, University of Saga, Saga, Japan.
Yasuhiro IkedaDepartment of Ophthalmology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Kensuke ShibataDepartment of Ophthalmology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
Koh-Hei SonodaDepartment of Ophthalmology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
Yusuke MurakamiDepartment of Ophthalmology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Neuroinflammation is triggered by the recognition of damage-associated molecular patterns (DAMPs) by pattern recognition receptors (PRRs). Toll-like receptors (TLRs)/MyD88 is the PRR pathway that mediates inflammatory signaling. We investigated the functions of Myd88 in retinal degeneration and neuroinflammation in a mouse model of retinitis pigmentosa (RP). Methods: Rd10 mice were crossed with Myd88-/- mice to produce rd10; Myd88-/- mice. The retinal phenotype was assessed by TUNEL, hematoxylin and eosin (H&E) staining, and electroretinography. Retinal microglia were immunostained with Iba-1. Retinal mRNA profiles associated with neuroinflammation were analyzed using a NanoString Neuroinflammation panel. Results: Myd88 deficiency increased the number of TUNEL-positive cells in the outer nuclear layer (ONL) and exacerbated ONL thinning at postnatal day 18 and 21 (P < 0.01, each). Consistent with these findings, the scotopic electroretinogram (ERG) showed lower b-wave amplitudes in rd10; Myd88-/- mice compared with rd10 mice (P < 0.01). Microglial infiltration into the outer retina showed an early but transient increase at P18, followed by a reduction at P21 in rd10; Myd88-/- mice. Retinal mRNA profiling revealed increased expression of Ifitm3 and Serpina3n, markers of astrocytic glia, in rd10; Myd88-/- mice. Immunostaining confirmed the upregulation of IFITM3 and SERPINA3N in astrocytes and Müller cells in rd10; Myd88-/- mice. Conclusions: Myd88 deficiency accelerates retinal degeneration in rd10 mice, accompanied by an earlier onset of microglial infiltration and altered glia-related gene expression.

Indexed as

MicrogliaMyeloid Differentiation Factor 88Retinal DegenerationRetinitis PigmentosaAnimalsDisease Models, AnimalElectroretinographyIn Situ Nick-End LabelingMiceMice, Inbred C57BLMice, KnockoutRetinaMyd88 protein, mouseMyeloid Differentiation Factor 88

Identifiers

PMID42383813
PMCPMC13332528

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.